Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 2, 2026, 4:00 PM EST
Vaxxinity Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| - | - | - | - | - | -0 | 0.05 | 0.05 | 0.07 | 0.07 | 0.13 | 0.57 | 0.56 | - | |
Revenue Growth (YoY) | - | - | - | - | - | - | -63.43% | -91.46% | -88.15% | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - | 0.01 | 1.94 | 1.94 | 1.94 | 1.75 | 0.05 | 0.05 | - |
Gross Profit | - | - | - | - | - | -0 | 0.04 | -1.89 | -1.87 | -1.87 | -1.62 | 0.52 | 0.51 | - |
Selling, General & Admin | 22.39 | 26.76 | 28.53 | 29.05 | 28.35 | 51.24 | 50.56 | 49.93 | 51.83 | 23.89 | 22.39 | 20.08 | 12.22 | 3.01 |
Research & Development | 35.9 | 40.7 | 45.25 | 47.57 | 47.63 | 51.66 | 62.89 | 71.17 | 71.38 | 62.79 | 46.96 | 30.43 | 20.57 | 10.66 |
Operating Expenses | 58.29 | 67.46 | 73.78 | 76.62 | 75.98 | 102.91 | 113.45 | 121.1 | 123.2 | 86.68 | 69.35 | 50.51 | 32.79 | 13.66 |
Operating Income | -58.29 | -67.46 | -73.78 | -76.62 | -75.98 | -102.91 | -113.41 | -122.98 | -125.08 | -88.55 | -70.97 | -49.99 | -32.28 | -13.66 |
Interest Expense | -0.7 | -0.76 | -0.64 | -0.6 | -0.51 | -0.37 | -0.43 | -0.43 | -0.84 | -1.18 | -1.39 | -1.5 | -1.18 | -0.44 |
Interest & Investment Income | 2.09 | 2.29 | 2.32 | 1.82 | 1.26 | 0.63 | 0.09 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | - |
Currency Exchange Gain (Loss) | -0.04 | -0.07 | -0.01 | 0.02 | 0.01 | 0.03 | -0 | -0.01 | -0.02 | -0.05 | -0.08 | -0.08 | -0.08 | -0.04 |
Other Non Operating Income (Expenses) | - | - | - | - | - | - | 2.67 | 2.67 | -8.58 | -9.6 | -15.67 | -16.69 | -6.42 | -0.03 |
EBT Excluding Unusual Items | -56.93 | -66 | -72.11 | -75.38 | -75.22 | -102.62 | -111.09 | -120.75 | -134.51 | -99.37 | -88.12 | -68.27 | -39.96 | -14.16 |
Other Unusual Items | - | - | - | - | - | - | -2.67 | -2.67 | -2.67 | -2.67 | - | - | - | - |
Pretax Income | -56.93 | -66 | -72.11 | -75.38 | -75.22 | -102.62 | -113.76 | -123.42 | -137.18 | -102.04 | -88.12 | -68.27 | -39.96 | -14.16 |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.06 |
Net Income | -56.93 | -66 | -72.11 | -75.38 | -75.22 | -102.62 | -113.76 | -123.42 | -137.18 | -102.04 | -88.12 | -68.27 | -39.96 | -14.22 |
Net Income to Common | -56.93 | -66 | -72.11 | -75.38 | -75.22 | -102.62 | -113.76 | -123.42 | -137.18 | -102.04 | -88.12 | -68.27 | -39.96 | -14.22 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 127 | 126 | 126 | 126 | 126 | 120 | 105 | 91 | 77 | 74 | 75 | 74 | 66 | 34 |
Shares Outstanding (Diluted) | 127 | 126 | 126 | 126 | 126 | 120 | 105 | 91 | 77 | 74 | 75 | 74 | 66 | 34 |
Shares Change (YoY) | 0.45% | 5.61% | 19.94% | 38.68% | 64.44% | 62.55% | 39.71% | 22.73% | 16.68% | - | - | - | 91.87% | - |
EPS (Basic) | -0.45 | -0.52 | -0.57 | -0.60 | -0.60 | -0.86 | -1.08 | -1.36 | -1.79 | -1.39 | -1.17 | -0.92 | -0.61 | -0.42 |
EPS (Diluted) | -0.45 | -0.52 | -0.57 | -0.60 | -0.60 | -0.86 | -1.08 | -1.36 | -1.79 | -1.39 | -1.17 | -0.92 | -0.61 | -0.42 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | -58.04 | -60.55 | -58.96 | -57.79 | -57.79 | -58.26 | -67.67 | -74.29 | -82.31 | -78.77 | -71.09 | -61.39 | -35.39 | -12.27 |
Free Cash Flow Per Share | -0.46 | -0.48 | -0.47 | -0.46 | -0.46 | -0.49 | -0.64 | -0.82 | -1.07 | -1.07 | -0.94 | -0.83 | -0.54 | -0.36 |
Gross Margin | - | - | - | - | - | - | 81.63% | - | - | - | - | 90.77% | 90.66% | - |
Operating Margin | - | - | - | - | - | - | -231453.06% | -250985.71% | -189507.58% | -132162.69% | -52962.69% | -8709.58% | -5795.69% | - |
Profit Margin | - | - | - | - | - | - | -232161.22% | -251871.43% | -207840.91% | -152297.02% | -65758.21% | -11893.21% | -7173.61% | - |
Free Cash Flow Margin | - | - | - | - | - | - | -138100.00% | -151620.41% | -124709.09% | -117564.18% | -53053.73% | -10695.12% | -6353.14% | - |
EBITDA | -56.05 | -65.14 | -71.71 | -74.69 | -74.3 | -101.59 | -112.15 | -121.83 | -123.97 | -87.27 | -69.81 | -49.02 | -31.57 | -13.55 |
D&A For EBITDA | 2.23 | 2.32 | 2.07 | 1.94 | 1.68 | 1.32 | 1.26 | 1.15 | 1.1 | 1.28 | 1.16 | 0.97 | 0.72 | 0.11 |
EBIT | -58.29 | -67.46 | -73.78 | -76.62 | -75.98 | -102.91 | -113.41 | -122.98 | -125.08 | -88.55 | -70.97 | -49.99 | -32.28 | -13.66 |